Search

Your search keyword '"Carlos Lumbreras"' showing total 264 results

Search Constraints

Start Over You searched for: Author "Carlos Lumbreras" Remove constraint Author: "Carlos Lumbreras"
264 results on '"Carlos Lumbreras"'

Search Results

1. Long Covid: a global health issue – a prospective, cohort study set in four continents

2. Corrigendum: Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

3. Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis

4. Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study

5. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

6. Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

7. Derivation and external validation of a simple prediction rule for the development of respiratory failure in hospitalized patients with influenza

8. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

9. Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry

10. Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs

11. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

12. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients

13. Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis

14. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

15. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

16. Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study

17. Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study

18. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination.

19. Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working Group

20. Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome

21. Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry.

22. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution

23. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID

24. Environmental Factors as Key Determinants for Visceral Leishmaniasis in Solid Organ Transplant Recipients, Madrid, Spain

25. High Prevalence of Insulin Resistance in Asymptomatic Patients with Acute Intermittent Porphyria and Liver-Targeted Insulin as a Novel Therapeutic Approach

26. Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry

27. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

28. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

30. Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients

31. Assessment of risk-adjusted mortality ratio (RAMR) in bloodstream infections using all-patient refined diagnosis-related groups (APR-DRGs).

32. 1980 - CARACTERÍSTICAS DE LOS PACIENTES QUE SE ESTUDIAN EN MEDICINA INTERNA POR PÉRDIDA DE PESO EN UN HOSPITAL DE TERCER NIVEL: ESTUDIO COMPARATIVO ENTRE PACIENTES INGRESADOS Y AMBULANTES

33. 2077 - DIFERENCIAS EN PACIENTES MAYORES Y MENORES DE 80 AÑOS ESTUDIADOS POR PÉRDIDA DE PESO EN UN SERVICIO DE MEDICINA INTERNA DE UN HOSPITAL TERCIARIO

35. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

36. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

37. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

38. Impacto de los días transcurridos desde el comienzo de los síntomas hasta la hospitalización en la mortalidad intrahospitalaria por COVID-19: el tiempo importa

39. COVID‐19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study

42. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

43. Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism

44. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

45. In‐hospital incidence of and risk factors for influenza‐associated respiratory failure

46. Author response for 'Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients'

47. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid

48. Soluble fms-like tyrosine kinase-1: a potential early predictor of respiratory failure in COVID-19 patients

49. Author response: Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study

50. Executive summary of the Consensus Document of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

Catalog

Books, media, physical & digital resources